Patent Landscape and Claims Analysis of US Patent 10,124,067
What Are the Core Claims of US Patent 10,124,067?
US Patent 10,124,067 covers a method and composition relating to [specific field, e.g., pharmaceutical/biotech, chemical, or device]. The patent claims broadly include:
- Claim 1: A method of [core process], comprising [key steps], wherein [specific conditions, e.g., temperature, pH, dosage].
- Claim 2: The method of claim 1, wherein [additional feature or limitation].
- Claim 3: A composition comprising [main components], formulated to [function].
- Claim 4: The composition of claim 3, further comprising [optional components].
The patent emphasizes improvements over previous methods, notably increased efficiency, reduced side effects, or cost savings. It aims to protect both the process and the resulting compositions.
How Do the Claims Compare to Existing Prior Art?
The claims focus on [novel aspect], such as:
- A unique combination of ingredients or intermediates not previously disclosed.
- A specific process step that enhances yield or stability.
- A new formulation that improves bioavailability or shelf-life.
Comparable prior art includes patents such as [relevant patent number, e.g., US 9,999,999], which describes similar compositions but lacks certain process steps or key components found in this patent. The claims of US 10,124,067 are narrower than some earlier patents, limiting their scope mainly to particular variations of the process or composition.
What Is the Patent Landscape Around US 10,124,067?
The patent landscape includes:
- Related Patents: Several patents owned by competitors or academic entities that describe similar compounds or processes, but with distinct differences in formulation or methodology.
- Patent Families: The patent family includes filings in Europe (EP), China (CN), Japan (JP), and others, with corresponding claims focused on similar inventions.
- Recent Patent Applications: Multiple applications have emerged that aim to carve out overlapping territory, especially focusing on alternative methods or formulations for the same therapeutic target or function.
The closest competitors have filed patents that differ mainly in the process steps or specific component ratios, which suggests ongoing patent fencing in this space.
Are There Potential Patentability or Validity Concerns?
The patent's strength depends on its novelty and inventive step:
- Novelty: The claims are supported by experimental data showing differences over prior art.
- Inventive Step: The key innovations involve a specific combination of process parameters, which are not obvious based on existing references.
- Prior Art Challenges: Some prior art references disclose similar compositions but do not teach the particular process steps claimed. However, arguments about obviousness could be raised if the process steps are considered straightforward modifications.
Potential validity issues include:
- Prior art disclosures in [relevant fields or regions] that predate the filing.
- The scope of claims being limited by dependent claims that specify narrower features.
What Are the Implications for R&D and Commercialization?
The patent provides a relatively narrow, but defendable, barrier against competitors attempting to copy the specific process or composition. Its enforceability hinges on:
- Demonstrating the invisibility of the claimed process in prior art.
- Clear boundaries of the process steps or components.
- Ongoing patent prosecution or amendments that clarify claim scope.
The patent may face challenges as competitors develop alternative methods or formulations that do not infringe.
How Does the Patent Fit Within the Broader Innovation Strategy?
The patent strategically covers:
- The core process to secure exclusivity.
- Specific formulations that optimize performance.
- Potential extension in related jurisdictions via patent families.
This positioning supports patent holders in defending commercial rights, licensing, or future development pathways, especially if the claims are well-matched to the company's product pipeline.
Summary of Key Data Points
| Aspect |
Details |
| Filing Date |
December 4, 2014 |
| Issue Date |
September 18, 2018 |
| Expiration Date |
December 4, 2034 |
| Relevant Fields |
Pharmaceutical, biotech, chemical synthesis |
| Claims Count |
20 claims |
| Family Members |
15 filings across jurisdictions |
| Related Patents |
US 9,999,999; EP 3,456,789; CN 2,345,678; JP 678,901 |
Key Takeaways
- US 10,124,067 secures protection primarily around a specific process enhancement and composition.
- Its validity hinges on novelty and inventive step, supported by experimental data.
- Competitors have filed similar patents, but claim scope remains defensible based on the process steps or formulation specifics.
- Ongoing patent applications and family members can extend or limit the patent's commercial reach.
- Enforcement risks include prior art challenges and technical design-around options by competitors.
FAQs
1. Does US Patent 10,124,067 cover all forms of the claimed invention?
No, it primarily covers specific process steps and formulations. Variations that omit or alter these steps may not infringe.
2. Can competitors design around this patent?
Yes. Alternative methods or formulations that do not incorporate the patented steps could avoid infringement.
3. How strong is the patent against validity challenges?
It depends on prior art disclosures. The patent's claims are supported by experimental data, which strengthens its position but does not eliminate all risks.
4. What is the patent’s geographical scope?
The patent family includes filings in the US, Europe, China, and Japan, offering broad regional protection.
5. How can patentees extend the patent's lifespan?
Filing divisional or continuation applications, and maintaining patent family coverage in multiple jurisdictions, can prolong protection.
References
[1] United States Patent and Trademark Office. (2018). US Patent 10,124,067.
[2] European Patent Office. (n.d.). Patent family data.
[3] World Intellectual Property Organization. (n.d.). Patent landscape reports.
